about
Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brainAbnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant miceFour-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.Human gene therapy and imaging in neurological diseases.Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis.Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical updateCentral nervous system drug development: an integrative biomarker approach toward individualized medicine.Molecular brain imaging in the multimodality era.Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.Monitoring protein aggregation and toxicity in Alzheimer's disease mouse models using in vivo imaging.Alzheimer disease therapy: can the amyloid cascade be halted?Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathyNanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imagingApplications of positron emission tomography (PET) in neurology.Inhibition of the NFAT pathway alleviates amyloid β neurotoxicity in a mouse model of Alzheimer's disease.Neuronal structure is altered by amyloid plaques.Direct detection of alpha synuclein oligomers in vivoA single dose of passive immunotherapy has extended benefits on synapses and neurites in an Alzheimer's disease mouse model.Mass spectrometry-based neurochemical analysis: perspectives for primate research.Small-molecule theranostic probes: a promising future in neurodegenerative diseases.The new neuroscience frontier: promoting neuroplasticity and brain repair in traumatic brain injury.Label-free imaging of amyloids using their intrinsic linear and nonlinear optical properties.Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease.APP transgenic mice: their use and limitations.Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.Rational design of amyloid binding agents based on the molecular rotor motif.A limited role for microglia in antibody mediated plaque clearance in APP mice.Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks.Targeting prion amyloid deposits in vivo.Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease.An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging.Association study of cathepsin D gene polymorphism in Iranian patients with sporadic late-onset Alzheimer's disease.Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.
P2860
Q24308258-E377FAB3-B6DE-4F7E-B5AB-800BA4565F12Q27339873-A54EDD47-F58F-4689-AADD-0B51BA0A51F8Q30481038-7EBE3E3F-F5DB-4FF8-8543-0AA16CFABFD9Q31023442-E10D8441-EBC8-4FFD-8BDD-6C2074566EF8Q33639513-39F72040-FFA7-40DC-B3B2-A7B706E6DC38Q33700069-CC2CF9DA-F606-4A7C-BCBF-C447632241E4Q33947007-6EFBDD52-476B-409C-BCA5-94BBB641262BQ34204125-E97A2BBF-013B-4A8E-A933-03AA4EFF7DBBQ34579152-74B07592-AD3C-43B7-A5B7-D1E57DCC5517Q34629165-0392370D-729E-4A50-ADAA-AD26E9D36895Q34828328-B0D28A22-287C-4298-9C5A-98AA3F6D30E9Q35053727-54965522-439C-4403-A69F-5665C05FDCEBQ35558668-B40C20E6-66F2-42D6-802F-0EDB60A7EEE9Q35748290-5B9D4885-A858-4F9B-A259-16488C104103Q35811072-E8636035-29BF-4711-B019-9F000590E470Q35939250-363FA5E9-E472-4374-B93F-85006D7FFC9DQ37180232-0CF830FD-0541-483A-B51A-7F97B4D5EE44Q37259695-CAAAF45A-C725-49AE-AC21-654247BF9360Q37304110-2EE13762-8E70-42E9-B52D-81964BA32E3AQ37353880-D86855DE-B7AD-44FF-9C81-BB0F70AD39A8Q37625946-55D63ACC-E9FE-49D9-AA8A-A766F7535448Q37671903-27051CE3-3A36-4C84-B9B1-CFBCC564D1C1Q37732549-9980F5B3-CED4-4C55-95BD-1D04CC7B6663Q37820330-D19DD773-5F9B-4DBE-836C-DEF4B187A354Q38853138-0C7FAC5F-BD00-49F0-9BD0-3A594FB7DB0DQ39591198-CA8DFF7B-12DA-4C75-B33A-902E225ECD24Q41886581-DC155AEA-1961-4750-B556-948AE4EF5429Q43246347-ED44B053-693F-4400-B7DF-5CE91C389080Q45004848-BBFC6E6C-00E9-49A9-9B16-2D49C3A2F186Q48423581-5300FC73-E512-4B09-97AE-08E23DF0537DQ52653207-C977E699-0973-4F44-9800-C4A52C19A82CQ53346513-9443821C-A63B-446A-BECF-029F782F7353Q55078779-80EC7C97-C3E6-49F1-B347-E44567DD71C1
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Imaging amyloid-beta deposits in vivo.
@ast
Imaging amyloid-beta deposits in vivo.
@en
type
label
Imaging amyloid-beta deposits in vivo.
@ast
Imaging amyloid-beta deposits in vivo.
@en
prefLabel
Imaging amyloid-beta deposits in vivo.
@ast
Imaging amyloid-beta deposits in vivo.
@en
P2093
P2860
P1476
Imaging amyloid-beta deposits in vivo.
@en
P2093
Brian J Bacskai
Chester A Mathis
William E Klunk
P2860
P304
P356
10.1097/00004647-200209000-00001
P577
2002-09-01T00:00:00Z
P6179
1031724636